\
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
September 29, 1999
------------------------------------------------
Date of Report (Date of earliest event reported)
INHALE THERAPEUTIC SYSTEMS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 023556 94-3134940
- ---------------------------- -------------------- --------------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
150 Industrial Road
San Carlos, CA 94070
----------------------------------------
(Address of principal executive offices)
(650) 631-3100
----------------------------------------------------
(Registrant's telephone number, including area code)
Inhale Therapeutic Systems
----------------------------------------------------
(Former name, if changed since last report)
1.
ITEM 5. OTHER EVENTS
On September 29, 1999, Inhale Therapeutic Systems, Inc. announced its
intention to issue $100 million aggregate principal amount of convertible
subordinated debentures ($120 million if the over-allotment option is
exercised in full). A press release relating to the issuance is attached
hereto as Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) Exhibits
99.1 Press Release dated September 29, 1999
2.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INHALE THERAPEUTIC SYSTEMS, INC.
Dated: September 29, 1999 By: /s/ Brigid A. Makes
------------------------------------------
Brigid A. Makes
Chief Financial Officer and Vice President
of Finance and Administration
3.